Study of Micro Albuminuria and Other Parameters in NIDDM Individuals

Similar documents
Comparison of Glucose & Lipid Profiles in Oxidative Stress Contain Diabetic Patients

BCH 447. Triglyceride Determination in Serum

Study of Impact of Serum Uric Acid in Type 2 Diabetic Patients And Its Relationship with Development of Complications

Triglyceride determination

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

International Journal of Health Sciences and Research ISSN:

Diabetic Nephropathy

EFFECT OF BIOCHEMICAL PARAMETERS SHOWING ATHEROGENICITY IN TYPE 2 DIABETIC NEPHROPATHY

CORRELATION BETWEEN SERUM LIPID PROFILE AND ALBUMINURIA IN NORMOTENSIVE DIABETIC SUBJECTS Dr.Abhijit Basu 1*, Dr J.S. Jhala 2

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

STUDY ON MICROALBUMINURIA AND OXIDATIVESTRESS IN DIABETICS. B. Suneel, R.R.Aparna, D.Balakrishna, B.Sowjanya and M.Audisesha Reddy.

Diabetic Nephropathy. Objectives:

A Comparitive Study of Biochemical Profile of Type I and II Diabetes Mellitus

Cardiovascular Risk Factors among Diabetic Patients Attending a Nigerian Teaching Hospital. O Alao, S Adebisi, G Jombo, D Joseph, O Damulak, F Puepet

Clinical Practice Guideline Key Points

Diabetes Overview. How Food is Digested

Serum uric acid levels and its association with type 2 diabetes mellitus. Received: / Revised Accepted: / Published:

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)

International Journal of Health Sciences and Research ISSN:

Diabetes and Heart Disease

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

A Comparison Of Diagnostic Accuracy Of Cystatin C With Creatinine In The Sample Of Patient Of T2 DM With Diabetic Nephropathy

Chapter (5) Etiology of Low HDL- Cholesterol

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

American Academy of Insurance Medicine

HBA1C: PREDICTOR OF DYSLIPIDEMIA AND ATHEROGENICITY IN DIABETES MELLITUS

A study of predictive value of microalbuminuria in early outcome of non-diabetic patients of acute myocardial infarction

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

Clinical Practice Guidelines for Diabetes Management

Evaluation. Abstract: Introduction: Micro-vascular. ESRD. Due ARTICLE 1,2. treatment for DM Bhubaneswar life span resulting 3 Tutor.

Local Anesthesia for Dental Hygienists Session III. Altered Consciousness and Diabetes Michael E. O Brien, DDS and Frank S.

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη

GESTATIONAL DIABETES: An Overview

The Diabetes Link to Heart Disease

JMSCR Vol 05 Issue 05 Page May 2017

Diabetes Mellitus (DM) - Dr Hiren Patt

Hormonal Regulations Of Glucose Metabolism & DM

Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients:

Echocardiographic study of left ventricular diastolic dysfunction in normotensive asymptomatic type II diabetes mellitus

Clinical Profile and Complications of UTI In Diabetic Patients

PREDIABETES TESTING SERVICES

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

Efficacy of Vamana followed by Nyagrodadi Churna in the management of sthula madhumeha (NIDDM)

Diabetes Mellitus Definition

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Diabetic Nephropathy

2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM. Gerti Tashko, M.D. DM Journal Club 1/21/2010

DIABETES MEASURES GROUP OVERVIEW

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

GLUCOSE HOMEOSTASIS/INSULIN PART - II

Welcome and Introduction

Pharmacoepidemiology of Macrovascular and Microvascular Complications in Type 2 Diabetes Mellitus Patients

Advanced Concepts of Personal Training Study Guide Answer Key

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Quantitative protein estimation of Urine

Note to the healthcare provider: The information is intended to familiarize you with the content of the Bayer Know Your Patient Education Materials.

Standards of Medical Care in Diabetes 2016

CLINICAL PROFILE OF TYPE 2 DIABETIC PATIENTS IN A TERTIARY CARE HOSPITAL IN COASTAL KARNATAKA

Pathophysiology of Lipid Disorders

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus Case Study

Update in Hypertension

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Index. Note: Page numbers of article titles are in boldface type.

associated with serious complications, but reduce occurrences with preventive measures

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Cardiac Pathophysiology

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

America s Foremost Insurance Brokerage Network Diabetes Guidelines

A Comparative Study of Thyroid Function in Patients of Type 2 Diabetes Mellitus without Nephropathy and Type 2 Diabetes Mellitus With Nephropathy.

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Modified version focused on CCNC Quality Measures and Feedback Processes

Inflammatory Biomarkers (Il-18, Hs-Crp) and Serum Lipids: A Novel Approach to Screen Early Diabetic Nephropathy

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT

The CARI Guidelines Caring for Australians with Renal Impairment. 4. Monitoring proteinuria in patients with suspected or known renal disease

Diabetes Complications Recognition and Treatment

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Monitoring Diabetes Mellitus with HBA 1 C: The Abakaliki, Nigeria Experience

Diabetes and Hypertension

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

Diabetes. Health Care Disparities: Medical Evidence. A Constellation of Complications. Every 24 hours.

SSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 5 May 2015

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia?

A study of micro vascular complications and associated risk factors in newly diagnosed patients of type 2 diabetes mellitus

The interest in microalbuminuria originated. Cardiovascular Implications of Albuminuria. R e v i e w P a p e r.

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P.

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Glucose, glucose oxidase/peroxidase method, photometry, diabetes mellitus.

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Diabetes. HED\ED:NS-BL 037-3rd

2013 Hypertension Measure Group Patient Visit Form

Transcription:

IOSR Journal of Dental and Medical Sciences (IOSRJDMS) eissn: 22790853, pissn: 22790861.Volume 15, Issue 2 Ver. I (Feb. 2016), PP 1418 www.iosrjournals.org Study of Albuminuria and Other Parameters in NIDDM Individuals Dr A.Navaneetha lakshmi 1, Dr B. Kiranmayi 2, Dr R.Tagore 3 Department of Biochemistry, Siddhartha medical college, DR.N.T.R.U.H.S, Vijayawada Abstract: Diabetes mellitus is a group of metabolic disorder carbohydrate metabolism in which glucose is under used producing hyperglycemia. As the disease progresses patients are at increased risk of development of specific complications including retinopathy, leading to blindness, nephropathy leading to renal failure, neuropathy, and atherosclerosis. Present study planned to review the degree of association in NIDDM patients with & other parameters like T.cholesterol and Triglycerides, HDL cholesterol. Present Study includes 50 cases (Males and Females) With NIDDM and 15 metabolically healthy individuals (Both sexes). All the individuals included are between the age group of 3070 yrs. All the cases were chosen from the O.P of Government General hospital, Vijayawada. In all these patients levels estimated with detailed history regarding complications of Diabetes noted. The incidence of dyslipidemia is noted in these individuals. There is increased incidence of micro in smokers, alcoholics and Hypertensive individuals of NIDDM patients Majority of them having Dyslipidemia. Aim: Study of risk factors like, T.Cholesterol etc., in NIDDM individuals. Inclusion criteria: 1. Diabetes with complications like Hypertension, Neuropathy 2. NIDDM Patients with age group of 3070 yrs Exclusion criteria: UTI and Chronic infections like TB, Acute febrile illness, H/O CHF, Patients with Nephropathy Keywords: Type II Diabetes mellitus,, T.cholesterol, Triglycerides, HDL Cholesterol I. Introduction Diabetes mellitus is a syndrome characterized by chronic hyperglycemia and disturbances of carbohydrate, fat and protein metabolism associated with absolute or relative deficiencies in insulin secretion and/ or insulin action. Diabetes mellitus is a group of metabolic disorder of carbohydrate metabolism in which glucose is under used producing hyperglycemia. As the disease progresses patients are at increased risk of development of specific complications including retinopathy, leading to blindness, nephropathy leading to renal failure, neuropathy, and atherosclerosis. In 1987 the prevalence of diagnosed diabetes was 6.8 million. In 1995 prevalence of diabetes in adults was estimated to be 4%. In 2001 the CDC (CENTER FOR DISEASE CONTROL) which estimated the prevalence of Diabetes is7.9% equivalent to16.7million In 2005 the Diabetes affects 300 million adults which is greater than 75% of who are living in the developing countries. This large increasing in the diabetes has been observed globally. These statistics revealed that the diabetes being described as one of the main threats to human health in the 21 century. The measurement of blood glucose remains the most important laboratory test in diabetes. But its inherent drawback is that it may change very quickly. Estimation of micro is valuable in monitoring diabetes mellitus, which helps to identify the increased risk of renal disease and cardiovascular mortality The present study was planned to review the degree of association between micro along with other parameters by a random survey of 50 patients of Type II Diabetes mellitus. The relationship between micro with Hypertension, cardiovascular disease in these patients was also studied. Incidentally there were few smokers and alcoholics among them. So I also studied the incidence of micro in them. Hypertension in diabetes increases incidence of retinopathy, increases incidence of renal disease and also increase progression of micro vascular disease. II. Materials And Methods Present Study includes 50 cases (Males and females) With NIDDM and 15 metabolically healthy individuals (Both sexes). All the individuals included are between the age group of 3070 yrs. All the cases were chosen from the OP of GGH, Vijayawada. Detailed case history was taken from both the groups regarding their habits, family history of Diabetes, duration of Diabetes Complications like Hypertension, Neuropathy and Cardiovascular disease.. DOI: 10.9790/085315211418 www.iosrjournals.org 14 Page

The Following Biochemical parameters were included along with. Fasting blood glucose by GODPOD method T.cholesterol by zlatkis, zak & boyles method S.tryglycerides by GPOPOD with ESPAS method HDL Cholesterol by CHOD/POD Phosphotungstate method (Pyrrogallol Red Method ) Principle: When the Pyrogallol red molybdate complex binds to basic amino acid groups of protein molecules there is a shift in reagent absorbance. The increase in absorbance at 600 nm is directly proportional to protein concentration in the sample. Kit Contents: Reagent 1 Dye reagent Reagent 2 Standard Reagent Composition: 1. Pyrogallol Red 0.05 % 2. Activators and stabilizers Specimen: Urine: Early morning midstream urine collected. III. Procedure Pipetted into test tubes which are labeled BLANK (B), STANDARD (S), And TEST as follows: Dye reagent B S T Standard Sample Water Mixed well incubated for 3 min at 37 C. Read Absorbance of Standard (S), and Test (T) against Blank (B) at 600 nm within 20 minutes. IV. Calculations Absorbance of test 100 Protein concentration mg/dl = Absorbance of Standard For conversion to 1000ml of urine multiplied by 10. Total protein excreted / 24hrs = Protein concentration in mgs /dl 10 volume of urine in 24 hrs. in liters. V. Results In the study 50 cases are NIDDM and 15 are sex matched apparently healthy normal individuals The Levels of Albuminuria with Duration Of Diabetes 05yrs 610yrs >11yrs >30mgs/day 86% 92% DOI: 10.9790/085315211418 www.iosrjournals.org 15 Page

Relationship between HTN & Albuminuria HTN NTN Hypertensives tensives 72% 68% 28% 32% Relationship between Family History of DM & Albuminuria individuals with family history micro normo Individuals with family history Individuals without family history 55% 45% DOI: 10.9790/085315211418 www.iosrjournals.org 16 Page

Relationship between Smokers and Smokers Smokers Non smokers 75% 32% 25% 68% Relationship between Dyslipidemia& Albuminuria Dyslipidemia Dyslipidemia lipidemia 55% 45% VI. Discussion Progression of micro to overt proteinuria is concerned; HTN is the most crucial factor in elderly NIDDM patients. In Type II diabetics, the lower the average blood glucose level, the lower the rate of nephropathy, retinopathy and neuropathy. A high risk of kidney disease noticed in smokers. In our study there is an increased incidence of micro in NIDDM smokers as compared to nonsmokers. In our present study there is positive correlation between increased levels of micro with family history of diabetes. is a major predictor of future nephropathy in diabetes mellitus. It has been identified as predictor of micro vascular disease and mortality. Because of difficulty in dating the onset of NIDDM, screening for should be performed at the time of diagnosis of these patients and annually thereafter. The development of in NIDDM patients is closely related to abnormality of lipid metabolism. In present study there is increased incidence of in smokers, hypertensive individuals of NIDDM patients. DOI: 10.9790/085315211418 www.iosrjournals.org 17 Page

Dyslipidemia (Triglycerides>150mg&HDL<35mg) in Type II DM is due to insulin resistance and obesity. Hyper triglyceridemia should not be delayed in patients with DM as this increase the risk of CHD. In present study out of 50 NIDDM patients 30 are dyslipidemia state. Prolonged hyperglycemia is a significant factor in causing micro. Albumin is subject to nonenzymatic glycation at increased rates and induces microvasculature in glomerulus that may lead to endothelial dysfunction and nephropathy. VII Conclusion Present study comprises a total of 65 subjects of which 50 were NIDDM patients and 15 metabolically healthy individuals 1. There is positive correlation between the severity of NIDDM as determined by. 2. Diabetic smokers have increased incidence of micro when compared to nonsmokers. 3. Higher percentage of micro was observed in diabetics with Dyslipidemia 4. It is also seen that people with family history of diabetes have higher incidence of micro than those without family history. References [1]. David B Sack s introduction of diabetes mellitusteitz textbook of clinical chemistry 3 rd edition [2]. Pamela C.Champe; Insulin resistance and obesity in Type11 DMLippincott Illustrated Reviews 3 rd Edition [3]. American Diabetes Association; position statement diabetic nephropathy, standards of medical care for patients with Diabetes mellitus, Diabetes care Vol 21 [4]. Monica Nanni pierri; increased capillary escape rate of Albumin in type11 Diabetic patients; Diabetes care Vol 18 [5]. Trinder P.Annals clinical biochemistry 6, 24, 29.Bergmayer.H.V (1974) Estimation of blood glucose, enzymatic analysis [6]. Edmund Lamb,, kidney function tests, carbohydrates urinary Albumin Excretion, Teitz text book of clinical chemistry 3 rd edition, pg.no.814, 886888. [7]. Tullio bertani, Diagnosis and management of nephropathy in patients with diabetes mellitus, diabetic nephropathy, consensus development conference, Aug 10121994.Diabetes care vol21,no3,pg 385. [8]. Henry N.bisulbery, Ira Igoldberg, Diabetes mellitus, Dyslipidemia, Harrison`s Text book of medicine, 15 th Edition pg no.2205&2245. [9]. Bennet P.H. and Diabetes, Assessment of urinary albumin excretion and its role in screening for Diabetic nephropathy, American journal of kidney diseases, vol13 no1 pg no 2934. [10]. Leo K Niskansen, Evolution, risk factors and prognostic Implications of Albuminuria in NIDDM Diabetes care, Vol 19.no5 pg.486 493. DOI: 10.9790/085315211418 www.iosrjournals.org 18 Page